CRO & CDMO Partner

CRO & CDMO Partner

To be an in-depth & trust-worthy CRO & CDMO Partner
Scientific & Rigorous, in search of excellence

Scientific & Rigorous, in search of excellence

Innovation & Change,high-efficiency operation
Integrity  Profession  Win-win Cooperation

Integrity Profession Win-win Cooperation

To provide excellent services and products

Who We Are

Beijing Hope Pharmaceutical Co., Ltd., established in 2005, is a high-tech enterprise with "chemical drug technology development-Process Optimization-Regulation registration and approval" as its core competence, and has won the title of "China Top 20 Pharmaceutical R&D Company" for several times. Hope Pharma actively builds one-stop service for drug CRO and CDMO, continuously expands its service areas, and establishes good cooperative relations with some leading pharmaceutical companies domestic and abroad.

 

Hope Pharma has over 16 years of experience in project evaluation, innovation-oriented patent around design, pre-clinical development, clinical trial practice, registration, marker authorization, etc.. Our products involve anti-tumor, anti-depressant, anti-epileptic, anxiolytic, cardiovascular and cerebrovascular, digestive system, respiratory system and other indications.

 

In finished products, Hope Pharma has accumulated rich experience in technical platforms such as sustained-release dosage, PLM-PtsE preparation platforms, and transdermal drug delivery, and has long-term accumulation for special reaction types (like nitrification, asymmetric catalysis, low temperature reaction) and chiral drugs. Until now, more than 100 technology transform, over 70 registration approvals and 40+ patents has been finished in Hope(including subsidiaries) for past 16 years, and has been rated as a national high-tech enterprise.

 

Hope Pharma currently has 3 production bases, passed the on-site audit of USFDA and PMDA, and a number of products have obtained CEP certificate and USDMF number, our products well exported to Europe, Japan, South Korea, Taiwan, India and other countries and regions.

  • 19

    years

    Focus on medicine development

  • 130

    +

    More than 130+ technology transfer succeeded

  • 60

    +

    Over 60+ invention patents applied

  • 30

    +

    More than 30+ series of products Industrial production

Milestones

2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2013
2012
2011
2008
2007
2006
2005
prev
next
National High-tech Enterprise Awarded for 17 consecutive years
Top 20 Chinese Pharmaceutical R&D Companies Awarded for 8 consecutive years
80+ Clinical approval & Production approval & New Drug Certificates
15+ International Registration (USDMF, CEP, etc. )Submitted
Accumulated more than 130 items of factory technology transfer to customer enterprises
prev
next
National High-tech Enterprise Awarded for 16 consecutive years
Top 20 Chinese Pharmaceutical R&D Companies Awarded for 7 consecutive years
70+ clinical approval & Production approval & New Drug Certificates
10+ International Registration (USDMF, CEP, etc. )Submitted
prev
next
20+ New Invention Patents Applied
2API products activated in CDE
5 finished formulation products approved for production license
Shanghai Branch was established. Strengthen business expansion and layout
prev
next
• Obtain the first CEP certificate
• Obtain CNAS certificate
• Submit MAH registration application for the first time and obtain B certificate
• Two API varieties have been approved by CDE and transferred to A
prev
next
• Jinghai Industrial Park R&D Center Operated
• Strategic Partnership with Zezheng Pharmaceutical Established
prev
next
• Subsidiary HMYA Established, International Business Operated Independently
• EU & FDA Application Submitted
• Top 20 Chinese Pharmaceutical R&D Companies Awarded (Reelected)
• CSAIII Pilot
• T100 New Technology & New Product Innovation Action Outstanding Enterprise Awarded
prev
next
• Strategic Partnership with PPC Group Established
• Top 20 Chinese Pharmaceutical R&D Companies Awarded (Reelected)
prev
next
• Strategic Partnership with Porton Pharmaceutical Established
• Top 20 Chinese Pharmaceutical R&D Companies Awarded
prev
next
• Subsidiary HMY Established, CRO Business Operated Independently

prev
next
• Subsidiary HMT Established, The Raw Materials & Intermediates Business Operated Independently
• Employee Stock Ownership Platform Established, Shareholding Reform Finished
prev
next
• The First Patent Certificate Awarded
prev
next
• The First New Drug Certificate Acquired
• Technology R & D Institution (Beijing) Awarded
• Audited by Foreign Clients
prev
next
• Equity Investment in Shandong Confucius Pharmaceutical
prev
next
• Strategic Partnership with Peking Chemical Heng-ye Established
prev
next
• National High-tech Enterprise Awarded
prev
next
• New Drug R & D Center Established
prev
next
• Hope Pharmaceutical Founded

News & Events

Hope

Subsidiaries

Beijing HMT Medical Technology Co., Ltd.
API & intermediate business

Beijing HMY Medical Technology Co., Ltd.
CRO business

Beijing HMYA Medical Technology Co., Ltd.
International business

  

Beijing Hope Pharmaceutical Co., Ltd.   京ICP备17065299号

这是描述信息